Piotr Stefan Sobieszczyk, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 6 | 2018 | 2365 | 1.050 |
Why?
|
| Superior Vena Cava Syndrome | 3 | 2020 | 53 | 0.970 |
Why?
|
| Brugada Syndrome | 2 | 2018 | 98 | 0.730 |
Why?
|
| Aortic Valve Stenosis | 7 | 2022 | 1930 | 0.700 |
Why?
|
| Vena Cava Filters | 3 | 2018 | 248 | 0.680 |
Why?
|
| Aortic Valve | 7 | 2022 | 1900 | 0.680 |
Why?
|
| Intermittent Claudication | 3 | 2015 | 309 | 0.600 |
Why?
|
| Peripheral Arterial Disease | 5 | 2023 | 1169 | 0.590 |
Why?
|
| Heart Valve Prosthesis Implantation | 7 | 2021 | 1515 | 0.580 |
Why?
|
| Coronary Restenosis | 2 | 2017 | 423 | 0.580 |
Why?
|
| Thrombolytic Therapy | 5 | 2016 | 2155 | 0.580 |
Why?
|
| Popliteal Artery | 2 | 2016 | 314 | 0.570 |
Why?
|
| Fibrinolytic Agents | 5 | 2015 | 2149 | 0.570 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2015 | 86 | 0.490 |
Why?
|
| Defibrillators, Implantable | 4 | 2018 | 1441 | 0.480 |
Why?
|
| Drug-Eluting Stents | 2 | 2017 | 753 | 0.440 |
Why?
|
| Angioplasty, Balloon | 4 | 2020 | 654 | 0.420 |
Why?
|
| Endovascular Procedures | 4 | 2023 | 1947 | 0.420 |
Why?
|
| Femoral Artery | 6 | 2023 | 841 | 0.420 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2016 | 1263 | 0.410 |
Why?
|
| Tachycardia, Ventricular | 7 | 2018 | 1271 | 0.410 |
Why?
|
| Brachytherapy | 2 | 2017 | 1247 | 0.400 |
Why?
|
| Femoral Neck Fractures | 1 | 2012 | 138 | 0.390 |
Why?
|
| Shock, Cardiogenic | 2 | 2015 | 668 | 0.390 |
Why?
|
| Heart Valve Prosthesis | 5 | 2021 | 1479 | 0.380 |
Why?
|
| Glycyrrhetinic Acid | 1 | 2010 | 18 | 0.380 |
Why?
|
| Anticoagulants | 5 | 2018 | 4582 | 0.370 |
Why?
|
| Vena Cava, Superior | 3 | 2020 | 193 | 0.360 |
Why?
|
| Ventricular Function, Right | 1 | 2012 | 591 | 0.330 |
Why?
|
| Ethanol | 5 | 2015 | 1329 | 0.320 |
Why?
|
| Exercise Therapy | 1 | 2015 | 897 | 0.310 |
Why?
|
| Thrombosis | 3 | 2018 | 2962 | 0.310 |
Why?
|
| Ultrasonography, Interventional | 2 | 2017 | 1480 | 0.300 |
Why?
|
| Aftercare | 1 | 2013 | 858 | 0.300 |
Why?
|
| Catheter Ablation | 7 | 2018 | 2737 | 0.290 |
Why?
|
| Thrombectomy | 2 | 2016 | 673 | 0.280 |
Why?
|
| Heart-Assist Devices | 2 | 2015 | 1191 | 0.280 |
Why?
|
| Vasodilation | 1 | 2010 | 945 | 0.280 |
Why?
|
| Electrocardiography | 3 | 2018 | 6425 | 0.270 |
Why?
|
| Angioplasty | 3 | 2015 | 363 | 0.270 |
Why?
|
| Constriction, Pathologic | 5 | 2019 | 1095 | 0.270 |
Why?
|
| Carotid Artery Diseases | 2 | 2015 | 878 | 0.260 |
Why?
|
| Catheterization | 2 | 2010 | 1466 | 0.260 |
Why?
|
| Stents | 7 | 2016 | 3257 | 0.260 |
Why?
|
| Device Removal | 4 | 2020 | 648 | 0.240 |
Why?
|
| Treatment Outcome | 26 | 2023 | 62691 | 0.240 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 1504 | 0.230 |
Why?
|
| Bioprosthesis | 2 | 2018 | 596 | 0.230 |
Why?
|
| Mitral Valve | 4 | 2021 | 1483 | 0.210 |
Why?
|
| Carotid Arteries | 1 | 2006 | 952 | 0.200 |
Why?
|
| Dyspnea | 3 | 2018 | 1295 | 0.180 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2014 | 3066 | 0.180 |
Why?
|
| Vascular Patency | 2 | 2013 | 888 | 0.170 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 3800 | 0.170 |
Why?
|
| Prosthesis Failure | 2 | 2018 | 1203 | 0.170 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2018 | 484 | 0.170 |
Why?
|
| Combined Modality Therapy | 4 | 2018 | 8605 | 0.170 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2021 | 271 | 0.160 |
Why?
|
| Brachiocephalic Veins | 1 | 2018 | 23 | 0.160 |
Why?
|
| Cough | 2 | 2018 | 552 | 0.150 |
Why?
|
| Cryosurgery | 2 | 2015 | 451 | 0.150 |
Why?
|
| Rehabilitation Centers | 1 | 2019 | 254 | 0.150 |
Why?
|
| Heart Aneurysm | 1 | 2017 | 120 | 0.150 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2017 | 144 | 0.140 |
Why?
|
| Humans | 54 | 2023 | 739219 | 0.140 |
Why?
|
| Electrodes, Implanted | 1 | 2020 | 821 | 0.140 |
Why?
|
| Bundle-Branch Block | 1 | 2018 | 270 | 0.140 |
Why?
|
| Ankle Brachial Index | 2 | 2013 | 154 | 0.130 |
Why?
|
| Endarterectomy, Carotid | 2 | 2014 | 543 | 0.130 |
Why?
|
| Hemodynamics | 4 | 2018 | 4196 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2013 | 205 | 0.130 |
Why?
|
| Credentialing | 1 | 2015 | 126 | 0.130 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2011 | 792 | 0.130 |
Why?
|
| Risk Assessment | 9 | 2020 | 23292 | 0.130 |
Why?
|
| Adenosine Monophosphate | 1 | 2016 | 277 | 0.120 |
Why?
|
| Female | 34 | 2022 | 378808 | 0.120 |
Why?
|
| Time Factors | 10 | 2021 | 40040 | 0.120 |
Why?
|
| Aged | 24 | 2021 | 162667 | 0.120 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2015 | 264 | 0.120 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2017 | 551 | 0.120 |
Why?
|
| Echocardiography | 3 | 2017 | 5098 | 0.120 |
Why?
|
| Male | 33 | 2023 | 348967 | 0.120 |
Why?
|
| Heart Failure | 3 | 2017 | 10793 | 0.120 |
Why?
|
| Recovery of Function | 4 | 2018 | 2924 | 0.110 |
Why?
|
| Vena Cava, Inferior | 1 | 2016 | 432 | 0.110 |
Why?
|
| Home Care Services | 1 | 2019 | 602 | 0.110 |
Why?
|
| Secondary Prevention | 2 | 2013 | 1516 | 0.110 |
Why?
|
| Arteriovenous Fistula | 1 | 2015 | 316 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 9812 | 0.100 |
Why?
|
| Risk Factors | 12 | 2023 | 71972 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2002 | 2505 | 0.100 |
Why?
|
| Forecasting | 1 | 2020 | 2952 | 0.100 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2015 | 342 | 0.100 |
Why?
|
| Leg | 2 | 2016 | 1106 | 0.100 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2010 | 16 | 0.100 |
Why?
|
| Pericardium | 1 | 2015 | 665 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2016 | 1874 | 0.090 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2010 | 66 | 0.090 |
Why?
|
| Cortisone | 1 | 2010 | 89 | 0.090 |
Why?
|
| Recurrence | 4 | 2016 | 8306 | 0.090 |
Why?
|
| Drug Approval | 1 | 2016 | 742 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 1058 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2018 | 1542 | 0.090 |
Why?
|
| Prosthesis Design | 4 | 2018 | 2110 | 0.090 |
Why?
|
| Embolectomy | 1 | 2010 | 120 | 0.090 |
Why?
|
| Ischemia | 2 | 2023 | 1908 | 0.090 |
Why?
|
| Vaccination | 1 | 2021 | 3232 | 0.080 |
Why?
|
| Body Surface Potential Mapping | 1 | 2010 | 238 | 0.080 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2012 | 550 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2019 | 3286 | 0.080 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 222 | 0.080 |
Why?
|
| Catheters | 1 | 2011 | 419 | 0.080 |
Why?
|
| Survival Rate | 3 | 2018 | 12760 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2018 | 1408 | 0.080 |
Why?
|
| Tetrazoles | 1 | 2013 | 831 | 0.080 |
Why?
|
| Physical Examination | 1 | 2013 | 1231 | 0.070 |
Why?
|
| Endocarditis, Bacterial | 1 | 2011 | 453 | 0.070 |
Why?
|
| Embolism | 1 | 2010 | 408 | 0.070 |
Why?
|
| Aspirin | 2 | 2013 | 3268 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2013 | 1477 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1528 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 2043 | 0.070 |
Why?
|
| Radial Artery | 1 | 2008 | 194 | 0.070 |
Why?
|
| Boston | 4 | 2023 | 9314 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 1232 | 0.070 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 851 | 0.070 |
Why?
|
| Stroke Volume | 2 | 2017 | 4941 | 0.070 |
Why?
|
| Limb Salvage | 2 | 2023 | 433 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 1910 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2011 | 538 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1673 | 0.070 |
Why?
|
| Lower Extremity | 2 | 2023 | 1145 | 0.070 |
Why?
|
| Equipment Design | 2 | 2011 | 3576 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 3620 | 0.060 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2010 | 591 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 2028 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2010 | 759 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 2867 | 0.060 |
Why?
|
| Adult | 11 | 2021 | 213375 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 15510 | 0.060 |
Why?
|
| Middle Aged | 16 | 2021 | 212833 | 0.060 |
Why?
|
| Hospital Mortality | 3 | 2019 | 5305 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1909 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 7897 | 0.060 |
Why?
|
| Angiography | 1 | 2008 | 1634 | 0.050 |
Why?
|
| Disease Management | 1 | 2013 | 2448 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2010 | 1810 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 13400 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 2014 | 2039 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 57639 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20038 | 0.050 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 1257 | 0.050 |
Why?
|
| Retrospective Studies | 8 | 2020 | 76632 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2016 | 1420 | 0.050 |
Why?
|
| Marital Status | 1 | 2022 | 435 | 0.050 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6410 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 11666 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2011 | 2711 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 1143 | 0.040 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 641 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 10208 | 0.040 |
Why?
|
| Cerebral Angiography | 2 | 2015 | 1282 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 28901 | 0.040 |
Why?
|
| Radiography | 1 | 2010 | 6997 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13237 | 0.040 |
Why?
|
| Stroke | 2 | 2014 | 9898 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 4454 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 38941 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2015 | 2614 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 12328 | 0.040 |
Why?
|
| Ticlopidine | 1 | 2002 | 899 | 0.040 |
Why?
|
| Livedo Reticularis | 1 | 2016 | 5 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2009 | 2781 | 0.040 |
Why?
|
| Tachycardia, Sinus | 1 | 2016 | 42 | 0.040 |
Why?
|
| Stockings, Compression | 1 | 2016 | 37 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2010 | 11985 | 0.030 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 129 | 0.030 |
Why?
|
| Aortography | 1 | 2018 | 429 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 364 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2016 | 519 | 0.030 |
Why?
|
| Aerospace Medicine | 1 | 2016 | 81 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 1941 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 2016 | 287 | 0.030 |
Why?
|
| Phlebography | 1 | 2016 | 333 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6294 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3510 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2010 | 8553 | 0.030 |
Why?
|
| Contrast Media | 1 | 2008 | 5287 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2011 | 1128 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 460 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2018 | 846 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2016 | 361 | 0.030 |
Why?
|
| Benchmarking | 1 | 2020 | 1035 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15035 | 0.030 |
Why?
|
| Pacemaker, Artificial | 1 | 2018 | 813 | 0.030 |
Why?
|
| Clinical Competence | 2 | 2020 | 4671 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2016 | 403 | 0.030 |
Why?
|
| Coronary Angiography | 2 | 2017 | 4556 | 0.030 |
Why?
|
| Acute Disease | 1 | 2002 | 7127 | 0.030 |
Why?
|
| Edema | 1 | 2016 | 791 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 5003 | 0.030 |
Why?
|
| Massachusetts | 2 | 2017 | 8668 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3233 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 2011 | 171 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2022 | 6517 | 0.020 |
Why?
|
| Thyroxine-Binding Proteins | 1 | 1990 | 24 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2015 | 788 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2018 | 1093 | 0.020 |
Why?
|
| Suction | 1 | 2011 | 267 | 0.020 |
Why?
|
| Heart Block | 1 | 2011 | 410 | 0.020 |
Why?
|
| Emergencies | 1 | 2016 | 1152 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1828 | 0.020 |
Why?
|
| Retreatment | 1 | 2011 | 603 | 0.020 |
Why?
|
| Hemoptysis | 1 | 2010 | 155 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1584 | 0.020 |
Why?
|
| Heparin | 1 | 2016 | 1637 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 821 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 2263 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15191 | 0.020 |
Why?
|
| Low Back Pain | 1 | 2016 | 948 | 0.020 |
Why?
|
| United States | 4 | 2020 | 69568 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 1123 | 0.020 |
Why?
|
| Wrist | 1 | 2008 | 222 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 2912 | 0.020 |
Why?
|
| Hypertension | 1 | 2006 | 8430 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2020 | 40385 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 681 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3095 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 4192 | 0.020 |
Why?
|
| Heart Atria | 1 | 2011 | 1341 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2017 | 2623 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7689 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2007 | 1309 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 56252 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2015 | 3738 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18002 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 2275 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 6247 | 0.010 |
Why?
|
| Hand | 1 | 2008 | 875 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 53036 | 0.010 |
Why?
|
| Curriculum | 1 | 2015 | 3575 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10248 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6364 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 1471 | 0.010 |
Why?
|
| Medicare | 1 | 2020 | 6497 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3606 | 0.010 |
Why?
|
| Aorta | 1 | 2009 | 2047 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2008 | 1165 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 2184 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5050 | 0.010 |
Why?
|
| Patient Selection | 1 | 2011 | 4211 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2011 | 9846 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29003 | 0.010 |
Why?
|
| Inpatients | 1 | 2008 | 2478 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1990 | 6537 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7134 | 0.010 |
Why?
|
| Obesity | 1 | 2014 | 12641 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 168358 | 0.010 |
Why?
|
| Asparagine | 1 | 1990 | 123 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 11699 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1990 | 575 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1800 | 0.000 |
Why?
|
| Base Sequence | 1 | 1990 | 12807 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1990 | 13815 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1990 | 18124 | 0.000 |
Why?
|
| DNA | 1 | 1990 | 7278 | 0.000 |
Why?
|
| Phenotype | 1 | 1990 | 16300 | 0.000 |
Why?
|
| Mutation | 1 | 1990 | 29659 | 0.000 |
Why?
|